History
- TOP
- History
| Year | Organization and Research Grant | Study Group |
|---|---|---|
| 1978 | Initial research was started, based on the grant "A Study on the Multidisciplinary Treatment of Cancer", funded by a Grant-in-Aid for Cancer Research from the Ministry of Health and Welfare. The Principal Investigator was Keiichi Suemasu, M.D. | The Lymphoma Study Group (LSG) The Japan Esophageal Oncology Group (JEOG) |
| 1982 | The Lung Cancer Study Group (LCSG) | |
| 1984 | The Gastric Cancer Surgical Study Group (GCSSG) (currently the Stomach Cancer Study Group) | |
| 1985 |
The Gastrointestinal Oncology Study Group (GIOSG)
Clinical Trial Review Committee (now Protocol Review Committee) Data and Safety Monitoring Committee |
|
| 1986 | Constitution and Bylaws established.The Clinical Trials Review Committee (currently the Protocol Review Committee) and Data and Safety Monitoring Committee were instituted. | The Lung Cancer Surgical Study Group (LCSSG) |
| 1987 | The Steering Committee Meeting (currently the Executive Committee Meeting) was established. | |
| 1988 | A new Grant-in-Aid was received from the Ministry of Health and Welfare , for a project titled "A Study on the Multidisciplinary Treatment of Solid Cancer". The Principal Investigator was Masanori Shimoyama, M.D. | |
| 1990 | The organization was named "JCOG (Japan Clinical Oncology Group)". Dr. Masanori Shimoyama became the first JCOG Chair. |
Autologous Bone Marrow Transplant Group |
| 1991 | The "JCOG Statistical Center" (now called the JCOG Data Center) was established, and began central patient registration and randomization using the minimization method. | |
| 1995 | The Gynecologic Cancer Study Group (GCSG) | |
| 1996 | Autologous Bone Marrow Transplant Group disbanded and merged into Lymphoma Study Group and Breast Cancer Study Group | |
| 1999 | "A Study on the Multidisciplinary Treatment of Solid Cancer" was divided into four groups:
|
JCOG8801 was published at The Lancet |
| 2000 |
Audit Comittee Education and Training Committee Surgical Committee Radiotherapy Committee |
|
| 2001 | Dr. Nagahiro Saijo became the second JCOG Chair. JCOG took part in the national project "Medical Frontier Strategy Research" (superseded since 2002 by "Clinical Research for Evidence Based Medicine") with a Health Sciences Research Grant. |
The Colorectal Cancer Study Group (CCSG)
Pathology Committee |
| 2002 |
The Bone and Soft Tissue Tumor Study Group (BSTTSG) JCOG9511 was published at New England Journal of Medicine |
|
| 2003 |
The Radiation Therapy Study Group (RTSG)
Clinical Research Professionals Committee |
|
| 2004 | A new competitive grant system from the Ministry of Health, Labour and Welfare was initiated, called "Health and Labour Sciences Research Grant for Clinical Cancer Research". | |
| 2005 | JCOG study activity incorporated a new Grant-in-Aid for Cancer Research, titled "Multi-institutional Cooperative Studies for the Establishment of Standard Therapy of Rare Malignant Tumors (17S-4)". |
Protocol Review Committee Translational Research Committee Regulatory Affairs Committee |
| 2006 | The JCOG central office was reorganized into the JCOG Data Center and JCOG Operations Office. The NPO CORE (Non-Profit Organization Clinical Oncology Research and Education) was established, collaboratively managing the JCOG Data Center / Operations Office with the National Cancer Center. |
|
| 2007 | The first investigator initiated registration trial called "JCOG0604" was initiated | |
| 2008 | A new Grant-in-Aid for Cancer Research, titled "Multi-institutional Cooperative Studies for the Establishment of Standard Therapy of Radiation Therapy (20S-5)" was added to the JCOG study activity. An international collaborative study with South Korea was begun. |
The Hepatobiliary and Pancreatic Oncology Group (HBPOG)
JCOG9501 was published at New England Journal of Medicine
The first international collaborative trial called "JCOG0705/KGCA01" was initiated
Diagnostic Radiology Committee |
| 2009 | Dr. Tomohide Tamura became the third JCOG Chair. | |
| 2010 | Conflict of Interest Committee | |
| 2011 | The Grant-in-Aid for Cancer Research was reorganized into the "National Cancer Center Research and Development Fund". JCOG activity was funded by 7 research grants: 23-A-16, 23-A-17, 23-A-18, 23-A-19, 23-A-20, 23-A-21, 23-A-22. |
The Gastrointestinal Endoscopy Study Group (GIESG)
JCOG Biobank was established |
| 2012 | The Dermatologic Oncology Group (DOG) | |
| 2013 | The first clinical trial called "JCOG1111C" was initiated in JCOG under the Advance Medical Care B | |
| 2014 | Seven research grants of National Cancer Center Research and Development Fund were integrated into 26-A-4 (Scientific research on multi-institutional trials to establish new standard treatment of solid tumors in adults) chaired by Dr. Kensei Tobinai. | |
| 2014 | Dr. Kensei Tobinai became the fourth JCOG Chair. | Start of collaboration with Biobank Japan (BBJ) |
| 2016 | Geriatric Study Committee | |
| 2017 |
Dr. Yuichiro Ohe became the fifth JCOG Chair.
|
|
| 2018 |
|
End of collaboration with Biobank Japan (BBJ) for genome analysis function |
| 2020 | National Cancer Center Research and Development was renewed as 2020-J-3 (Scientific research on multi-institutional trials to establish new standard treatment of solid tumors in adults: JCOG) | |
| 2021 | PRO/QOL research committee | |
| 2022 |
Patient and Public Involvement Committee JCOG0802/WJOG4607L was published at The Lancet |
|
| 2023 | National Cancer Center Research and Development was renewed as 2023-J-03 (Scientific research on multi-institutional trials to establish new standard treatment of solid tumors in adults: JCOG) | JCOG1202 was pulished at The Lancet |
| 2024 |
International Committee JCOG1109 was pulished at The Lancet |
|
| 2025 | Dr. Yukihide Kanemitsu became the sixth JCOG Chair. |
The detailed structure and history of JCOG can be found in the following article:
Fukuda H. Development of Cancer Cooperative Groups in Japan. Jpn J Clin Oncol 2010;40(9)881-890.